 | Arrowhead Pharmaceuticals, Inc. | |||
| NMS : ARWR || Location: United States | ||||
$22.12+0.25 (+1.14%) |
0.11 M | 21.72 - 22.34 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 8.866 M |
| March 28, 2024 | 8.869 M |
| March 15, 2024 | 9.203 M |
| Feb. 29, 2024 | 8.839 M |
| Feb. 15, 2024 | 8.771 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.84 | -1.24 | -48.25% |
| 09/30/2023 | -0.62 | -1.02 | -65.77% |
| 06/30/2023 | -0.67 | -0.96 | -44.12% |
| 03/31/2023 | -0.65 | 0.45 | 168.84% |
| 12/31/2022 | 0.45 | -0.39 | -187.62% |
ARWR Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 123.897M | Shares Float | 118.946M |
| Short Float | 8.866M | Market Cap | 2709.63M |
| Institution ownership | 67.12% | Insider ownership | 4.490% |
| Earnings Date | 05/07/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -2.77 | Forward EPS | -2.66 |